Immunotherapy cannot cure mesothelioma, but it can help you live longer. At this point in time, no one has been cured of this aggressive cancer, but advancements in diagnostics and treatment have ...

Pleural mesothelioma is an aggressive disease that is enriched for inactivating alterations in tumor suppressor genes. Systemic therapeutic strategies for pleural mesothelioma generally involve ...

Mesothelioma is a rare type of cancer, most often caused by exposure to asbestos, according to the U.S. Centers for Disease Control and Prevention (CDC). Mesothelioma develops in the thin tissue ...

Prasad Adusumilli and colleagues have shown that CAR T cells that start to lose power can be revived by immunotherapy drugs given several weeks later. Mesothelioma is a rare cancer that affects the ...

VT3989 targets TEAD proteins in the Hippo pathway, aiming to inhibit cancer cell growth in mesothelioma. Orphan drug designation offers benefits like tax credits, FDA fee exemptions, and market ...

VT3989, a transcriptional enhanced associate domain autopalmitoylation inhibitor, targets the Hippo pathway in mesothelioma treatment. The FDA's fast track designation aims to expedite VT3989's ...

Malignant peritoneal mesothelioma is a rare and aggressive cancer that develops in the lining around the abdominal organs. Doctors usually treat it with surgery and chemotherapy. Peritoneal ...